Open original FDA record ↗Recall record
- FDA identifier
- Z-1196-2018
- Company in FDA record
- Zimmer Biomet, Inc.
- FDA classification date
- Mar 14, 2018
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
The AIM Tibial Nails failed a clinical analysis where the surgical revision rate exceeded the acceptance criteria in the Device Performance Review protocol for the implant system.
Source facts
- Action
- Zimmer Biomet sent an Urgent Medical Device Recall letter dated February 06, 2018 to affected customers. The letter identified the affected product, problem and actions to be taken. Customers were instructed to: 1. Review this notification and notify affected personnel of the contents. 2. Quarantine all affected product. Your Zimmer Biomet sales representative will remove it from your facility. 3. Complete the Certificate of Acknowledgement and send to CorporateQuality.PostMarket@zimmerbiomet.com. DISTRIBUTOR: 1. Review this notification and notify affected team members of the contents.2. Quarantine affected product in your inventory. 3.Return affected product from your distributorship and from affected hospitals within your territory. a. Complete Inventory Return Certification Form and send to CorporateQuality.PostMarket@zimmerbiomet.com within three (3) days. b. International returns, request an International Return Authorization (IRA) Number by emailing zimmerbiometintlirarequests@zimmerbiomet.com 4. Return the Additional Accounts form to CorporateQuality.PostMarket@zimmerbiomet.com.
- Initiated
- 2018-02-06
- Root cause
- Under Investigation by firm
- Terminated
- 2019-04-02
- Distribution
- Worldwide and US of Indiana and country of the Republic of Korea.
- Recall number
- Z-1196-2018
- Recall status
- Terminated
- CDRH record ID
- 162237
- FDA classified
- 2018-03-14
- Recall event number
- 79409